Innate Pharma Files its 2020 Universal Registration Document (Document d’Enregistrement Universel) and 2020 Annual Report on Form 20-F

NEXT STORY
Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER
PREV STORY
US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for PD-L1-positive, metastatic triple-negative breast cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect Completes Enrollment in Phase 2 Clinical Trial Evaluating CF-301 (exebacase) in Patients with Staphylococcus Aureus Bacteremia

Company remains on track to announce top-line results in Q4 2018YONKERS, N.Y., Sept. 06, ...

author_avatar
NASDAQ Market News

Aptose to Present CG-806 and APTO-253 Data at the 2020 ASH Annual Meeting

author_avatar
NASDAQ Market News

Biocartis Group NV: Studies on Idylla(TM) MSI and RAS liquid biopsy tests to be presented at ESMO congress

    PRESS RELEASE: 19 October 2018, 07:00 CEST Studies on Idylla(TM) MSI and ...

author_avatar
NASDAQ Market News